U.S. Markets close in 3 hrs, 33 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,289.37 | -20.55 | -0.20% |
| NASDAQ | 2,126.98 | -11.46 | -0.54% |
| S&P 500 | 1,089.06 | -2.43 | -0.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.25 | Current P/E Ratio: | -16.398 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.01 | Current Quarter Estimate: | -0.012 |
| Last Fiscal Year Earnings: | -0.07 | Next Fiscal Year Estimate: | -0.044 |
| Analyst Consensus: | — | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation
-2147483648 Analysts Reporting
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 12/07/2009 * | 18:00 | Q2 2010 Peregrine Pharmaceuticals Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 09/03/2009 | Q1 2010 Peregrine Pharmaceuticals Earnings Conference Call | — | Download($) |
| 09/03/2009 | Q1 2010 Peregrine Pharmaceuticals Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts